أعرض في EDS

Non-alcoholic fatty liver disease: A patient guideline

التفاصيل البيبلوغرافية
العنوان:	Non-alcoholic fatty liver disease: A patient guideline
المؤلفون:	Shira Zelber-Sagi, Rebecca Dorner, Giulio Marchesini, Marko Korenjak, Christos Lionis, Jeffrey V. Lazarus, Sven Francque, Achim Kautz, Luca Busetto, José Willemse, G. Koek, Dror Dicker, Kate Hallsworth, Shlomo Vinker, Gema Frühbeck, Euan Woodward, Mehmet Ungan, Juan M. Mendive, Martine Walmsley
المساهمون:	Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health
المصدر:	JHEP Reports JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021) JHEP Reports, 3(5):100322. Elsevier BV
سنة النشر:	2021
مصطلحات موضوعية:	NASH, non-alcoholic steatohepatiti, Y GASTRIC BYPASS, Disease, RC799-869, PLACEBO-CONTROLLED TRIAL, LIFE-STYLE MODIFICATION, cardiovascular disease, LDL, low-density lipoprotein, HEPATOCELLULAR-CARCINOMA, non-invasive test, T2D, GLP-1 RAs, glucagon-like receptor 1 agonists, European Association for the Study of Obesity, HCC, Gastroenterology, NASH, specific, Diseases of the digestive system. Gastroenterology, CAP, controlled attenuation parameter, CT, computed tomography, FXR, ASH, alcoholic steatohepatitis, GP, non-alcoholic steatohepatitis, GLP-1 RAs, glucagon-like receptor 1 agonist, LDL, low-density lipoproteins, medicine.medical_specialty, HDL, achievable, NASH, non-alcoholic steatohepatitis, T2D, type 2 diabetes, high-density lipoprotein, CVD, cardiovascular disease, LDL, Patient Guideline, Quality of life (healthcare), FXR, farnesoid X receptor, NAFLD, low-density lipoproteins, GP, general practitioner, NAFL, non-alcoholic fatty liver, FIB-4, fibrosis-4 index, Intensive care medicine, computed tomography, Guideline, medicine.disease, T1D, type 1 diabete, digestive system diseases, NIT, Human medicine, farnesoid X receptor, type 1 diabetes, BMI, body mass index, EASL, European Association for the Study of the Liver, Placebo-controlled study, Chronic liver disease, GLP-1 RAs, QUALITY-OF-LIFE, alcoholic steatohepatitis, European Association for the Study of Diabetes, EASD, European Association for the Study of Diabetes, Immunology and Allergy, magnetic resonance imaging, NASH Clinical Research Network, ALD, alcohol-related or alcoholic liver disease, Disease management (health), glucagon-like receptor 1 agonists, EASO, European Association for the Study of Obesity, NASH CRN, NASH Clinical Research Network, ASH, alcoholic steatohepatiti, Fatty liver, timely, hepatocellular carcinoma, CVD, magnetic resonance elastography, MRE, NAFL, FIB-4, non-alcoholic fatty liver, type 2 diabetes, T1D, type 1 diabetes, CAP, controlled attenuation parameter, CT, European Association for the Study of the Liver, MRI, fibrosis-4 index, NAFLD, non-alcoholic fatty liver disease, EASD, HDL, high-density lipoprotein, UNITED-STATES, ASH, body mass index, EASL, measurable, BMI, NIT, non-invasive test, Internal Medicine, medicine, NASH CRN, HEPATIC STEATOSIS, HCC, hepatocellular carcinoma, MRE, magnetic resonance elastography, MRI, magnetic resonance imaging, SMART, specific, measurable, achievable, relevant, timely, Disease burden, BARIATRIC SURGERY, Hepatology, SMART, business.industry, SERUM ALANINE AMINOTRANSFERASE, non-alcoholic fatty liver disease, PHYSICAL-ACTIVITY, alcohol-related or alcoholic liver disease, EASD, European Association for the Study of Diabete, EASO, ALD, general practitioner, relevant, T1D, business
الوصف:	This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which has an important impact on the information that is given (or not) to patients. Its management requires a close interaction between patients and their many healthcare providers. It is important for patients to develop a full understanding of NAFLD in order to enable them to take an active role in their disease management. This guide summarises the current knowledge relevant to NAFLD and its management. It has been developed by patients, patient representatives, clinicians and scientists and is based on current scientific recommendations, intended to support patients in making informed decisions. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
وصف الملف:	ELETTRONICO
تدمد:	2589-5559
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1Test https://pubmed.ncbi.nlm.nih.gov/34693236Test
حقوق:	OPEN
رقم الانضمام:	edsair.doi.dedup.....cc5e84bfe19b52d5e0324b299615b0e1
قاعدة البيانات:	OpenAIRE

ResultId	1
Header	edsair OpenAIRE edsair.doi.dedup.....cc5e84bfe19b52d5e0324b299615b0e1 863 3 unknown 863.325805664063
PLink	https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cc5e84bfe19b52d5e0324b299615b0e1&custid=s6537998&authtype=sso
FullText	Array ( [Availability] => 0 )
Items	Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Non-alcoholic fatty liver disease: A patient guideline ) Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Shira+Zelber-Sagi%22">Shira Zelber-Sagi</searchLink><br /><searchLink fieldCode="AR" term="%22Rebecca+Dorner%22">Rebecca Dorner</searchLink><br /><searchLink fieldCode="AR" term="%22Giulio+Marchesini%22">Giulio Marchesini</searchLink><br /><searchLink fieldCode="AR" term="%22Marko+Korenjak%22">Marko Korenjak</searchLink><br /><searchLink fieldCode="AR" term="%22Christos+Lionis%22">Christos Lionis</searchLink><br /><searchLink fieldCode="AR" term="%22Jeffrey+V%2E+Lazarus%22">Jeffrey V. Lazarus</searchLink><br /><searchLink fieldCode="AR" term="%22Sven+Francque%22">Sven Francque</searchLink><br /><searchLink fieldCode="AR" term="%22Achim+Kautz%22">Achim Kautz</searchLink><br /><searchLink fieldCode="AR" term="%22Luca+Busetto%22">Luca Busetto</searchLink><br /><searchLink fieldCode="AR" term="%22José+Willemse%22">José Willemse</searchLink><br /><searchLink fieldCode="AR" term="%22G%2E+Koek%22">G. Koek</searchLink><br /><searchLink fieldCode="AR" term="%22Dror+Dicker%22">Dror Dicker</searchLink><br /><searchLink fieldCode="AR" term="%22Kate+Hallsworth%22">Kate Hallsworth</searchLink><br /><searchLink fieldCode="AR" term="%22Shlomo+Vinker%22">Shlomo Vinker</searchLink><br /><searchLink fieldCode="AR" term="%22Gema+Frühbeck%22">Gema Frühbeck</searchLink><br /><searchLink fieldCode="AR" term="%22Euan+Woodward%22">Euan Woodward</searchLink><br /><searchLink fieldCode="AR" term="%22Mehmet+Ungan%22">Mehmet Ungan</searchLink><br /><searchLink fieldCode="AR" term="%22Juan+M%2E+Mendive%22">Juan M. Mendive</searchLink><br /><searchLink fieldCode="AR" term="%22Martine+Walmsley%22">Martine Walmsley</searchLink> ) Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Francque, Sven M<br />Marchesini, Giulio<br />Kautz, Achim<br />Walmsley, Martine<br />Dorner, Rebecca<br />Lazarus, Jeffrey V<br />Zelber-Sagi, Shira<br />Hallsworth, Kate<br />Busetto, Luca<br />Frühbeck, Gema<br />Dicker, Dror<br />Woodward, Euan<br />Korenjak, Marko<br />Willemse, José<br />Koek, Gerardus H<br />Vinker, Shlomo<br />Ungan, Mehmet<br />Mendive, Juan M<br />Lionis, Christos<br />Interne Geneeskunde<br />MUMC+: MA Maag Darm Lever (9)<br />RS: NUTRIM - R2 - Liver and digestive health ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => JHEP Reports<br />JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)<br />JHEP Reports, 3(5):100322. Elsevier BV ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2021 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22NASH%2C+non-alcoholic+steatohepatiti%22">NASH, non-alcoholic steatohepatiti</searchLink><br /><searchLink fieldCode="DE" term="%22Y+GASTRIC+BYPASS%22">Y GASTRIC BYPASS</searchLink><br /><searchLink fieldCode="DE" term="%22Disease%22">Disease</searchLink><br /><searchLink fieldCode="DE" term="%22RC799-869%22">RC799-869</searchLink><br /><searchLink fieldCode="DE" term="%22PLACEBO-CONTROLLED+TRIAL%22">PLACEBO-CONTROLLED TRIAL</searchLink><br /><searchLink fieldCode="DE" term="%22LIFE-STYLE+MODIFICATION%22">LIFE-STYLE MODIFICATION</searchLink><br /><searchLink fieldCode="DE" term="%22cardiovascular+disease%22">cardiovascular disease</searchLink><br /><searchLink fieldCode="DE" term="%22LDL%2C+low-density+lipoprotein%22">LDL, low-density lipoprotein</searchLink><br /><searchLink fieldCode="DE" term="%22HEPATOCELLULAR-CARCINOMA%22">HEPATOCELLULAR-CARCINOMA</searchLink><br /><searchLink fieldCode="DE" term="%22non-invasive+test%22">non-invasive test</searchLink><br /><searchLink fieldCode="DE" term="%22T2D%22">T2D</searchLink><br /><searchLink fieldCode="DE" term="%22GLP-1+RAs%2C+glucagon-like+receptor+1+agonists%22">GLP-1 RAs, glucagon-like receptor 1 agonists</searchLink><br /><searchLink fieldCode="DE" term="%22European+Association+for+the+Study+of+Obesity%22">European Association for the Study of Obesity</searchLink><br /><searchLink fieldCode="DE" term="%22HCC%22">HCC</searchLink><br /><searchLink fieldCode="DE" term="%22Gastroenterology%22">Gastroenterology</searchLink><br /><searchLink fieldCode="DE" term="%22NASH%22">NASH</searchLink><br /><searchLink fieldCode="DE" term="%22specific%22">specific</searchLink><br /><searchLink fieldCode="DE" term="%22Diseases+of+the+digestive+system%2E+Gastroenterology%22">Diseases of the digestive system. Gastroenterology</searchLink><br /><searchLink fieldCode="DE" term="%22CAP%22">CAP</searchLink><br /><searchLink fieldCode="DE" term="%22controlled+attenuation+parameter%22">controlled attenuation parameter</searchLink><br /><searchLink fieldCode="DE" term="%22CT%2C+computed+tomography%22">CT, computed tomography</searchLink><br /><searchLink fieldCode="DE" term="%22FXR%22">FXR</searchLink><br /><searchLink fieldCode="DE" term="%22ASH%2C+alcoholic+steatohepatitis%22">ASH, alcoholic steatohepatitis</searchLink><br /><searchLink fieldCode="DE" term="%22GP%22">GP</searchLink><br /><searchLink fieldCode="DE" term="%22non-alcoholic+steatohepatitis%22">non-alcoholic steatohepatitis</searchLink><br /><searchLink fieldCode="DE" term="%22GLP-1+RAs%2C+glucagon-like+receptor+1+agonist%22">GLP-1 RAs, glucagon-like receptor 1 agonist</searchLink><br /><searchLink fieldCode="DE" term="%22LDL%2C+low-density+lipoproteins%22">LDL, low-density lipoproteins</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22HDL%22">HDL</searchLink><br /><searchLink fieldCode="DE" term="%22achievable%22">achievable</searchLink><br /><searchLink fieldCode="DE" term="%22NASH%2C+non-alcoholic+steatohepatitis%22">NASH, non-alcoholic steatohepatitis</searchLink><br /><searchLink fieldCode="DE" term="%22T2D%2C+type+2+diabetes%22">T2D, type 2 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22high-density+lipoprotein%22">high-density lipoprotein</searchLink><br /><searchLink fieldCode="DE" term="%22CVD%2C+cardiovascular+disease%22">CVD, cardiovascular disease</searchLink><br /><searchLink fieldCode="DE" term="%22LDL%22">LDL</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+Guideline%22">Patient Guideline</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+life+%28healthcare%29%22">Quality of life (healthcare)</searchLink><br /><searchLink fieldCode="DE" term="%22FXR%2C+farnesoid+X+receptor%22">FXR, farnesoid X receptor</searchLink><br /><searchLink fieldCode="DE" term="%22NAFLD%22">NAFLD</searchLink><br /><searchLink fieldCode="DE" term="%22low-density+lipoproteins%22">low-density lipoproteins</searchLink><br /><searchLink fieldCode="DE" term="%22GP%2C+general+practitioner%22">GP, general practitioner</searchLink><br /><searchLink fieldCode="DE" term="%22NAFL%2C+non-alcoholic+fatty+liver%22">NAFL, non-alcoholic fatty liver</searchLink><br /><searchLink fieldCode="DE" term="%22FIB-4%2C+fibrosis-4+index%22">FIB-4, fibrosis-4 index</searchLink><br /><searchLink fieldCode="DE" term="%22Intensive+care+medicine%22">Intensive care medicine</searchLink><br /><searchLink fieldCode="DE" term="%22computed+tomography%22">computed tomography</searchLink><br /><searchLink fieldCode="DE" term="%22Guideline%22">Guideline</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22T1D%2C+type+1+diabete%22">T1D, type 1 diabete</searchLink><br /><searchLink fieldCode="DE" term="%22digestive+system+diseases%22">digestive system diseases</searchLink><br /><searchLink fieldCode="DE" term="%22NIT%22">NIT</searchLink><br /><searchLink fieldCode="DE" term="%22Human+medicine%22">Human medicine</searchLink><br /><searchLink fieldCode="DE" term="%22farnesoid+X+receptor%22">farnesoid X receptor</searchLink><br /><searchLink fieldCode="DE" term="%22type+1+diabetes%22">type 1 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22BMI%2C+body+mass+index%22">BMI, body mass index</searchLink><br /><searchLink fieldCode="DE" term="%22EASL%2C+European+Association+for+the+Study+of+the+Liver%22">EASL, European Association for the Study of the Liver</searchLink><br /><searchLink fieldCode="DE" term="%22Placebo-controlled+study%22">Placebo-controlled study</searchLink><br /><searchLink fieldCode="DE" term="%22Chronic+liver+disease%22">Chronic liver disease</searchLink><br /><searchLink fieldCode="DE" term="%22GLP-1+RAs%22">GLP-1 RAs</searchLink><br /><searchLink fieldCode="DE" term="%22QUALITY-OF-LIFE%22">QUALITY-OF-LIFE</searchLink><br /><searchLink fieldCode="DE" term="%22alcoholic+steatohepatitis%22">alcoholic steatohepatitis</searchLink><br /><searchLink fieldCode="DE" term="%22European+Association+for+the+Study+of+Diabetes%22">European Association for the Study of Diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22EASD%2C+European+Association+for+the+Study+of+Diabetes%22">EASD, European Association for the Study of Diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology+and+Allergy%22">Immunology and Allergy</searchLink><br /><searchLink fieldCode="DE" term="%22magnetic+resonance+imaging%22">magnetic resonance imaging</searchLink><br /><searchLink fieldCode="DE" term="%22NASH+Clinical+Research+Network%22">NASH Clinical Research Network</searchLink><br /><searchLink fieldCode="DE" term="%22ALD%2C+alcohol-related+or+alcoholic+liver+disease%22">ALD, alcohol-related or alcoholic liver disease</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+management+%28health%29%22">Disease management (health)</searchLink><br /><searchLink fieldCode="DE" term="%22glucagon-like+receptor+1+agonists%22">glucagon-like receptor 1 agonists</searchLink><br /><searchLink fieldCode="DE" term="%22EASO%2C+European+Association+for+the+Study+of+Obesity%22">EASO, European Association for the Study of Obesity</searchLink><br /><searchLink fieldCode="DE" term="%22NASH+CRN%2C+NASH+Clinical+Research+Network%22">NASH CRN, NASH Clinical Research Network</searchLink><br /><searchLink fieldCode="DE" term="%22ASH%2C+alcoholic+steatohepatiti%22">ASH, alcoholic steatohepatiti</searchLink><br /><searchLink fieldCode="DE" term="%22Fatty+liver%22">Fatty liver</searchLink><br /><searchLink fieldCode="DE" term="%22timely%22">timely</searchLink><br /><searchLink fieldCode="DE" term="%22hepatocellular+carcinoma%22">hepatocellular carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22CVD%22">CVD</searchLink><br /><searchLink fieldCode="DE" term="%22magnetic+resonance+elastography%22">magnetic resonance elastography</searchLink><br /><searchLink fieldCode="DE" term="%22MRE%22">MRE</searchLink><br /><searchLink fieldCode="DE" term="%22NAFL%22">NAFL</searchLink><br /><searchLink fieldCode="DE" term="%22FIB-4%22">FIB-4</searchLink><br /><searchLink fieldCode="DE" term="%22non-alcoholic+fatty+liver%22">non-alcoholic fatty liver</searchLink><br /><searchLink fieldCode="DE" term="%22type+2+diabetes%22">type 2 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22T1D%2C+type+1+diabetes%22">T1D, type 1 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22CAP%2C+controlled+attenuation+parameter%22">CAP, controlled attenuation parameter</searchLink><br /><searchLink fieldCode="DE" term="%22CT%22">CT</searchLink><br /><searchLink fieldCode="DE" term="%22European+Association+for+the+Study+of+the+Liver%22">European Association for the Study of the Liver</searchLink><br /><searchLink fieldCode="DE" term="%22MRI%22">MRI</searchLink><br /><searchLink fieldCode="DE" term="%22fibrosis-4+index%22">fibrosis-4 index</searchLink><br /><searchLink fieldCode="DE" term="%22NAFLD%2C+non-alcoholic+fatty+liver+disease%22">NAFLD, non-alcoholic fatty liver disease</searchLink><br /><searchLink fieldCode="DE" term="%22EASD%22">EASD</searchLink><br /><searchLink fieldCode="DE" term="%22HDL%2C+high-density+lipoprotein%22">HDL, high-density lipoprotein</searchLink><br /><searchLink fieldCode="DE" term="%22UNITED-STATES%22">UNITED-STATES</searchLink><br /><searchLink fieldCode="DE" term="%22ASH%22">ASH</searchLink><br /><searchLink fieldCode="DE" term="%22body+mass+index%22">body mass index</searchLink><br /><searchLink fieldCode="DE" term="%22EASL%22">EASL</searchLink><br /><searchLink fieldCode="DE" term="%22measurable%22">measurable</searchLink><br /><searchLink fieldCode="DE" term="%22BMI%22">BMI</searchLink><br /><searchLink fieldCode="DE" term="%22NIT%2C+non-invasive+test%22">NIT, non-invasive test</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+Medicine%22">Internal Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22NASH+CRN%22">NASH CRN</searchLink><br /><searchLink fieldCode="DE" term="%22HEPATIC+STEATOSIS%22">HEPATIC STEATOSIS</searchLink><br /><searchLink fieldCode="DE" term="%22HCC%2C+hepatocellular+carcinoma%22">HCC, hepatocellular carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22MRE%2C+magnetic+resonance+elastography%22">MRE, magnetic resonance elastography</searchLink><br /><searchLink fieldCode="DE" term="%22MRI%2C+magnetic+resonance+imaging%22">MRI, magnetic resonance imaging</searchLink><br /><searchLink fieldCode="DE" term="%22SMART%2C+specific%2C+measurable%2C+achievable%2C+relevant%2C+timely%22">SMART, specific, measurable, achievable, relevant, timely</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+burden%22">Disease burden</searchLink><br /><searchLink fieldCode="DE" term="%22BARIATRIC+SURGERY%22">BARIATRIC SURGERY</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatology%22">Hepatology</searchLink><br /><searchLink fieldCode="DE" term="%22SMART%22">SMART</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22SERUM+ALANINE+AMINOTRANSFERASE%22">SERUM ALANINE AMINOTRANSFERASE</searchLink><br /><searchLink fieldCode="DE" term="%22non-alcoholic+fatty+liver+disease%22">non-alcoholic fatty liver disease</searchLink><br /><searchLink fieldCode="DE" term="%22PHYSICAL-ACTIVITY%22">PHYSICAL-ACTIVITY</searchLink><br /><searchLink fieldCode="DE" term="%22alcohol-related+or+alcoholic+liver+disease%22">alcohol-related or alcoholic liver disease</searchLink><br /><searchLink fieldCode="DE" term="%22EASD%2C+European+Association+for+the+Study+of+Diabete%22">EASD, European Association for the Study of Diabete</searchLink><br /><searchLink fieldCode="DE" term="%22EASO%22">EASO</searchLink><br /><searchLink fieldCode="DE" term="%22ALD%22">ALD</searchLink><br /><searchLink fieldCode="DE" term="%22general+practitioner%22">general practitioner</searchLink><br /><searchLink fieldCode="DE" term="%22relevant%22">relevant</searchLink><br /><searchLink fieldCode="DE" term="%22T1D%22">T1D</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which has an important impact on the information that is given (or not) to patients. Its management requires a close interaction between patients and their many healthcare providers. It is important for patients to develop a full understanding of NAFLD in order to enable them to take an active role in their disease management. This guide summarises the current knowledge relevant to NAFLD and its management. It has been developed by patients, patient representatives, clinicians and scientists and is based on current scientific recommendations, intended to support patients in making informed decisions. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => ELETTRONICO ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 2589-5559 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1</link><br /><link linkTarget="URL" linkTerm="https://pubmed.ncbi.nlm.nih.gov/34693236" linkWindow="_blank">https://pubmed.ncbi.nlm.nih.gov/34693236</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....cc5e84bfe19b52d5e0324b299615b0e1 )
RecordInfo	Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => Undetermined ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => NASH, non-alcoholic steatohepatiti [Type] => general ) [1] => Array ( [SubjectFull] => Y GASTRIC BYPASS [Type] => general ) [2] => Array ( [SubjectFull] => Disease [Type] => general ) [3] => Array ( [SubjectFull] => RC799-869 [Type] => general ) [4] => Array ( [SubjectFull] => PLACEBO-CONTROLLED TRIAL [Type] => general ) [5] => Array ( [SubjectFull] => LIFE-STYLE MODIFICATION [Type] => general ) [6] => Array ( [SubjectFull] => cardiovascular disease [Type] => general ) [7] => Array ( [SubjectFull] => LDL, low-density lipoprotein [Type] => general ) [8] => Array ( [SubjectFull] => HEPATOCELLULAR-CARCINOMA [Type] => general ) [9] => Array ( [SubjectFull] => non-invasive test [Type] => general ) [10] => Array ( [SubjectFull] => T2D [Type] => general ) [11] => Array ( [SubjectFull] => GLP-1 RAs, glucagon-like receptor 1 agonists [Type] => general ) [12] => Array ( [SubjectFull] => European Association for the Study of Obesity [Type] => general ) [13] => Array ( [SubjectFull] => HCC [Type] => general ) [14] => Array ( [SubjectFull] => Gastroenterology [Type] => general ) [15] => Array ( [SubjectFull] => NASH [Type] => general ) [16] => Array ( [SubjectFull] => specific [Type] => general ) [17] => Array ( [SubjectFull] => Diseases of the digestive system. Gastroenterology [Type] => general ) [18] => Array ( [SubjectFull] => CAP [Type] => general ) [19] => Array ( [SubjectFull] => controlled attenuation parameter [Type] => general ) [20] => Array ( [SubjectFull] => CT, computed tomography [Type] => general ) [21] => Array ( [SubjectFull] => FXR [Type] => general ) [22] => Array ( [SubjectFull] => ASH, alcoholic steatohepatitis [Type] => general ) [23] => Array ( [SubjectFull] => GP [Type] => general ) [24] => Array ( [SubjectFull] => non-alcoholic steatohepatitis [Type] => general ) [25] => Array ( [SubjectFull] => GLP-1 RAs, glucagon-like receptor 1 agonist [Type] => general ) [26] => Array ( [SubjectFull] => LDL, low-density lipoproteins [Type] => general ) [27] => Array ( [SubjectFull] => medicine.medical_specialty [Type] => general ) [28] => Array ( [SubjectFull] => HDL [Type] => general ) [29] => Array ( [SubjectFull] => achievable [Type] => general ) [30] => Array ( [SubjectFull] => NASH, non-alcoholic steatohepatitis [Type] => general ) [31] => Array ( [SubjectFull] => T2D, type 2 diabetes [Type] => general ) [32] => Array ( [SubjectFull] => high-density lipoprotein [Type] => general ) [33] => Array ( [SubjectFull] => CVD, cardiovascular disease [Type] => general ) [34] => Array ( [SubjectFull] => LDL [Type] => general ) [35] => Array ( [SubjectFull] => Patient Guideline [Type] => general ) [36] => Array ( [SubjectFull] => Quality of life (healthcare) [Type] => general ) [37] => Array ( [SubjectFull] => FXR, farnesoid X receptor [Type] => general ) [38] => Array ( [SubjectFull] => NAFLD [Type] => general ) [39] => Array ( [SubjectFull] => low-density lipoproteins [Type] => general ) [40] => Array ( [SubjectFull] => GP, general practitioner [Type] => general ) [41] => Array ( [SubjectFull] => NAFL, non-alcoholic fatty liver [Type] => general ) [42] => Array ( [SubjectFull] => FIB-4, fibrosis-4 index [Type] => general ) [43] => Array ( [SubjectFull] => Intensive care medicine [Type] => general ) [44] => Array ( [SubjectFull] => computed tomography [Type] => general ) [45] => Array ( [SubjectFull] => Guideline [Type] => general ) [46] => Array ( [SubjectFull] => medicine.disease [Type] => general ) [47] => Array ( [SubjectFull] => T1D, type 1 diabete [Type] => general ) [48] => Array ( [SubjectFull] => digestive system diseases [Type] => general ) [49] => Array ( [SubjectFull] => NIT [Type] => general ) [50] => Array ( [SubjectFull] => Human medicine [Type] => general ) [51] => Array ( [SubjectFull] => farnesoid X receptor [Type] => general ) [52] => Array ( [SubjectFull] => type 1 diabetes [Type] => general ) [53] => Array ( [SubjectFull] => BMI, body mass index [Type] => general ) [54] => Array ( [SubjectFull] => EASL, European Association for the Study of the Liver [Type] => general ) [55] => Array ( [SubjectFull] => Placebo-controlled study [Type] => general ) [56] => Array ( [SubjectFull] => Chronic liver disease [Type] => general ) [57] => Array ( [SubjectFull] => GLP-1 RAs [Type] => general ) [58] => Array ( [SubjectFull] => QUALITY-OF-LIFE [Type] => general ) [59] => Array ( [SubjectFull] => alcoholic steatohepatitis [Type] => general ) [60] => Array ( [SubjectFull] => European Association for the Study of Diabetes [Type] => general ) [61] => Array ( [SubjectFull] => EASD, European Association for the Study of Diabetes [Type] => general ) [62] => Array ( [SubjectFull] => Immunology and Allergy [Type] => general ) [63] => Array ( [SubjectFull] => magnetic resonance imaging [Type] => general ) [64] => Array ( [SubjectFull] => NASH Clinical Research Network [Type] => general ) [65] => Array ( [SubjectFull] => ALD, alcohol-related or alcoholic liver disease [Type] => general ) [66] => Array ( [SubjectFull] => Disease management (health) [Type] => general ) [67] => Array ( [SubjectFull] => glucagon-like receptor 1 agonists [Type] => general ) [68] => Array ( [SubjectFull] => EASO, European Association for the Study of Obesity [Type] => general ) [69] => Array ( [SubjectFull] => NASH CRN, NASH Clinical Research Network [Type] => general ) [70] => Array ( [SubjectFull] => ASH, alcoholic steatohepatiti [Type] => general ) [71] => Array ( [SubjectFull] => Fatty liver [Type] => general ) [72] => Array ( [SubjectFull] => timely [Type] => general ) [73] => Array ( [SubjectFull] => hepatocellular carcinoma [Type] => general ) [74] => Array ( [SubjectFull] => CVD [Type] => general ) [75] => Array ( [SubjectFull] => magnetic resonance elastography [Type] => general ) [76] => Array ( [SubjectFull] => MRE [Type] => general ) [77] => Array ( [SubjectFull] => NAFL [Type] => general ) [78] => Array ( [SubjectFull] => FIB-4 [Type] => general ) [79] => Array ( [SubjectFull] => non-alcoholic fatty liver [Type] => general ) [80] => Array ( [SubjectFull] => type 2 diabetes [Type] => general ) [81] => Array ( [SubjectFull] => T1D, type 1 diabetes [Type] => general ) [82] => Array ( [SubjectFull] => CAP, controlled attenuation parameter [Type] => general ) [83] => Array ( [SubjectFull] => CT [Type] => general ) [84] => Array ( [SubjectFull] => European Association for the Study of the Liver [Type] => general ) [85] => Array ( [SubjectFull] => MRI [Type] => general ) [86] => Array ( [SubjectFull] => fibrosis-4 index [Type] => general ) [87] => Array ( [SubjectFull] => NAFLD, non-alcoholic fatty liver disease [Type] => general ) [88] => Array ( [SubjectFull] => EASD [Type] => general ) [89] => Array ( [SubjectFull] => HDL, high-density lipoprotein [Type] => general ) [90] => Array ( [SubjectFull] => UNITED-STATES [Type] => general ) [91] => Array ( [SubjectFull] => ASH [Type] => general ) [92] => Array ( [SubjectFull] => body mass index [Type] => general ) [93] => Array ( [SubjectFull] => EASL [Type] => general ) [94] => Array ( [SubjectFull] => measurable [Type] => general ) [95] => Array ( [SubjectFull] => BMI [Type] => general ) [96] => Array ( [SubjectFull] => NIT, non-invasive test [Type] => general ) [97] => Array ( [SubjectFull] => Internal Medicine [Type] => general ) [98] => Array ( [SubjectFull] => medicine [Type] => general ) [99] => Array ( [SubjectFull] => NASH CRN [Type] => general ) [100] => Array ( [SubjectFull] => HEPATIC STEATOSIS [Type] => general ) [101] => Array ( [SubjectFull] => HCC, hepatocellular carcinoma [Type] => general ) [102] => Array ( [SubjectFull] => MRE, magnetic resonance elastography [Type] => general ) [103] => Array ( [SubjectFull] => MRI, magnetic resonance imaging [Type] => general ) [104] => Array ( [SubjectFull] => SMART, specific, measurable, achievable, relevant, timely [Type] => general ) [105] => Array ( [SubjectFull] => Disease burden [Type] => general ) [106] => Array ( [SubjectFull] => BARIATRIC SURGERY [Type] => general ) [107] => Array ( [SubjectFull] => Hepatology [Type] => general ) [108] => Array ( [SubjectFull] => SMART [Type] => general ) [109] => Array ( [SubjectFull] => business.industry [Type] => general ) [110] => Array ( [SubjectFull] => SERUM ALANINE AMINOTRANSFERASE [Type] => general ) [111] => Array ( [SubjectFull] => non-alcoholic fatty liver disease [Type] => general ) [112] => Array ( [SubjectFull] => PHYSICAL-ACTIVITY [Type] => general ) [113] => Array ( [SubjectFull] => alcohol-related or alcoholic liver disease [Type] => general ) [114] => Array ( [SubjectFull] => EASD, European Association for the Study of Diabete [Type] => general ) [115] => Array ( [SubjectFull] => EASO [Type] => general ) [116] => Array ( [SubjectFull] => ALD [Type] => general ) [117] => Array ( [SubjectFull] => general practitioner [Type] => general ) [118] => Array ( [SubjectFull] => relevant [Type] => general ) [119] => Array ( [SubjectFull] => T1D [Type] => general ) [120] => Array ( [SubjectFull] => business [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Non-alcoholic fatty liver disease: A patient guideline [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Shira Zelber-Sagi ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Rebecca Dorner ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Giulio Marchesini ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Marko Korenjak ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Christos Lionis ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Jeffrey V. Lazarus ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Sven Francque ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Achim Kautz ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Luca Busetto ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => José Willemse ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => G. Koek ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dror Dicker ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kate Hallsworth ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Shlomo Vinker ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Gema Frühbeck ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Euan Woodward ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mehmet Ungan ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Juan M. Mendive ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Martine Walmsley ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Francque, Sven M ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Marchesini, Giulio ) ) ) [21] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kautz, Achim ) ) ) [22] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Walmsley, Martine ) ) ) [23] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dorner, Rebecca ) ) ) [24] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lazarus, Jeffrey V ) ) ) [25] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Zelber-Sagi, Shira ) ) ) [26] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hallsworth, Kate ) ) ) [27] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Busetto, Luca ) ) ) [28] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Frühbeck, Gema ) ) ) [29] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dicker, Dror ) ) ) [30] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Woodward, Euan ) ) ) [31] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Korenjak, Marko ) ) ) [32] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Willemse, José ) ) ) [33] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Koek, Gerardus H ) ) ) [34] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Vinker, Shlomo ) ) ) [35] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ungan, Mehmet ) ) ) [36] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mendive, Juan M ) ) ) [37] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lionis, Christos ) ) ) [38] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Interne Geneeskunde ) ) ) [39] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => MUMC+: MA Maag Darm Lever (9) ) ) ) [40] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => RS: NUTRIM - R2 - Liver and digestive health ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 27 [M] => 05 [Type] => published [Y] => 2021 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 25895559 ) [1] => Array ( [Type] => issn-locals [Value] => edsair ) [2] => Array ( [Type] => issn-locals [Value] => edsairFT ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 3 ) [1] => Array ( [Type] => issue [Value] => 5 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => JHEP reports : innovation in hepatology [Type] => main ) ) ) ) ) ) )
IllustrationInfo